Active Pharma Inc.
Active Pharma Inc., headquartered in California, is a prominent player in the pharmaceutical industry, specialising in the development and distribution of innovative healthcare solutions. Founded in [year], the company has established a strong presence across major operational regions, focusing on both prescription and over-the-counter products. With a commitment to quality and efficacy, Active Pharma Inc. offers a diverse range of core products, including advanced formulations and generics that cater to various therapeutic areas. Their unique approach to research and development has positioned them as a trusted name in the market, achieving notable milestones in product launches and regulatory approvals. Recognised for their dedication to improving patient outcomes, Active Pharma Inc. continues to enhance its market position through strategic partnerships and a robust pipeline of future innovations.
DitchCarbon Score
How does Active Pharma Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Active Pharma Inc.'s score of 18 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Active Pharma Inc.'s reported carbon emissions
In 2023, Active Pharma Inc. reported total carbon emissions of approximately 11,168,000 kg CO2e from Scope 1 and about 43,425,000 kg CO2e from Scope 2. This indicates a significant commitment to transparency in their emissions reporting. The company has disclosed emissions data for both Scope 1 and Scope 2, but there is no available data for Scope 3 emissions. In 2024, emissions increased, with Scope 1 emissions reaching about 33,489,000 kg CO2e and Scope 2 emissions at approximately 43,622,000 kg CO2e. This rise in emissions highlights the ongoing challenges the company faces in managing its carbon footprint. Despite the lack of specific reduction targets or initiatives outlined in their reports, Active Pharma Inc. continues to engage in climate commitments, reflecting an awareness of the industry's need for sustainable practices. The company’s emissions intensity for Scope 1 and 2 combined was reported at 8,890 kg CO2e per tonne in 2023 and 10,890 kg CO2e per tonne in 2024, indicating a need for further action to improve efficiency and reduce overall emissions. Active Pharma Inc.'s headquarters is located in California, where regulatory frameworks increasingly demand accountability and action on climate change. The absence of defined reduction targets suggests an opportunity for the company to enhance its sustainability strategy and align with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 11,168,000 | 00,000,000 |
| Scope 2 | 43,425,000 | 00,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Active Pharma Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
